stockrow
Friday 6 November 2026
Export PRVA’s income statement to Excel — free account
Privia Health Group, Inc.
PRVA Healthcare Health Information Services
Privia Health Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.1 billion, up 22.3% from fiscal 2024.
- Revenue
- +13.2%
- EPS
- +90.7%
- Free cash flow
- −44.4%
Quarter to September 2026, against a year earlier
24.32
0.38
+1.59%
Follow PRVA
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
131.72 | 121.00 | 116.95 | 71.76 |
P/S ratio |
1.36 | 1.14 | 1.38 | 1.03 | |
P/FCF ratio |
17.76 | 18.55 | 24.80 | 23.30 | |
P/Operating CF |
22.72 | (51.63) | 2,950.08 | 86.78 | |
P/B ratio |
3.66 | 3.17 | 3.87 | 2.88 | |
Price to Tangible BV |
7.93 | 6.66 | 8.04 | 5.68 | |
EV/Sales |
1.15 | 0.96 | 1.21 | 0.86 | |
EV/EBITDA |
55.47 | 45.38 | 50.31 | 32.85 | |
EV/Operating CF |
14.99 | 15.69 | 21.84 | 19.40 | |
EV/FCF |
15.01 | 15.73 | 21.89 | 19.45 | |
Quick Ratio |
1.55 | 1.55 | 1.55 | 1.59 | |
Current Ratio |
1.60 | 1.61 | 1.62 | 1.63 | |
Net Debt/EBITDA |
(34.42) | (39.20) | (27.25) | 0.00 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
1.69 | 1.73 | 1.71 | 1.67 | |
Operating CF/Net income |
13.93 | (16.14) | 0.12 | 2.15 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
6.60% | 8.22% | 7.53% | 6.76% | |
Intangible Assets out of Total Assets |
0.31 | 0.30 | 0.29 | 0.28 | |
Share Based Compensation of Revenue |
2.86% | 3.63% | 3.07% | 2.14% | |
Graham Net Nets |
0.11 | 0.14 | 0.12 | 0.16 | |
Graham Number |
5.12 | 4.98 | 5.74 | 6.50 | |
Earnings Yield |
0.76% | 0.83% | 0.86% | 1.39% | |
Free Cash Flow Yield |
5.63% | 5.39% | 4.03% | 4.29% | |
Revenue per Share |
4.43 | 4.86 | 5.02 | 5.15 | |
Operating CF per Share |
1.04 | (0.40) | 0.01 | 0.23 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
1.04 | (0.40) | 0.01 | 0.23 | |
Cash per Share |
3.93 | 3.38 | 3.27 | 3.50 | |
Shareholders Equity per Share |
6.47 | 6.49 | 6.65 | 6.84 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
6.47 | 6.49 | 6.65 | 6.84 | |
Free Cash Flow |
127.50 | (49.46) | 1.10 | 28.94 | |
Working Capital |
342.48 | 364.72 | 390.82 | 425.20 | |
Net Current Asset Value |
332.57 | 354.03 | 374.76 | 408.76 | |
EV/EBIT |
71.52 | 59.44 | 63.83 | 41.09 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Operating Income |
84.62 | 70.09 | 72.31 | 49.23 | |
| Other line items | |||||
Average Receivables |
358.54 | 451.20 | 509.08 | 561.31 | |
Average Payables |
89.40 | 74.35 | 82.65 | 92.21 | |
Average Assets |
1,252.58 | 1,300.72 | 1,380.56 | 1,457.35 | |
Average Common Equity |
737.20 | 757.72 | 785.81 | 817.84 |
Columns are period end dates · fundamentals updated 6 Nov 2026